• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Mar 23;28(5).
doi: 10.3201/eid2805.220278. Online ahead of print.
SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

Jackie Kleynhans, Stefano Tempia, Nicole Wolter, Anne von Gottberg, Jinal N Bhiman, Amelia Buys, Jocelyn Moyes, Meredith L McMorrow, Kathleen Kahn, F Xavier Gómez-Olivé, Stephen Tollman, Neil A Martinson, Floidy Wafawanaka, Limakatso Lebina, Jacques D du Toit, Waasila Jassat, Mzimasi Neti, Marieke Brauer, Cheryl Cohen, PHIRST-C Group1

Abstract

By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rural community and 70% in an urban community. High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity observed in the fourth wave.

Keywords: COVID-19; SARS-CoV-2; case-to-infection ratio; coronavirus disease; fatality-to-infection ratio; hospitalization-to-infection ratio; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; vaccine-preventable diseases; viruses; zoonoses.
 
Back
Top Bottom